Streetbeat News

Products Services

DNUT

Krispy Kreme Inc (NASDAQ:DNUT) has partnered with M&M'S to create four doughnuts. The new M&M'S collection will be available from July 17 for a limited time at participating shops across the U.S. DNUT shares closed lower by 0.71% at $15.35 on Friday.

Portfolio Pulse from Shivani Kumaresan

July 17, 2023 | 11:42 am

BBIO

BridgeBio's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid cardiomyopathy has met its primary endpoint, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:41 am

QCOM

DigiTimes reports that Qualcomm (QCOM) and Mediatek are relying on India's handset recovery to clear their inventory. This suggests that the companies are expecting an increase in demand for their products in the Indian market.

Portfolio Pulse from Charles Gross

July 17, 2023 | 11:36 am

CTVA

EVGN

Evogene's subsidiary, Lavie Bio, has announced a licensing agreement for bio-fungicides with Corteva Agriscience. The agreement grants Corteva the rights to further develop and commercialize bio-fungicide product candidates.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:33 am

BIVI

Biovie has announced data from a Phase 2 exploratory biomarker study, detailing the epigenetic basis for how its NE3107 may have potentially regulated specific genes. This regulation is significantly correlated with observed cognitive and biomarker improvements.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:16 am

VIRI

Virios Therapeutics has announced data showing improvement in multiple long-Covid symptoms following treatment with a combination of Valacyclovir and Celecoxib. The data comes from an exploratory, open-label, proof of concept study.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:10 am

CLSD

Clearside Biomedical has announced the enrollment of multiple participants in its ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) in Wet AMD.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:10 am

ATHA

Athira Pharma has presented new preclinical data at the Alzheimer's Association International Conference in Amsterdam, demonstrating the neuroprotective effects of fosgonimeton in models of amyloid-ß-mediated toxicity. Additionally, ATH-1105 has shown protection against pathologies common to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:09 am

CGEN

Compugen Ltd. has announced that the European Patent Office has successfully maintained broad claims of its anti-PVRIG antibodies for use in treating cancer patients.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:08 am

IVVD

Invivyd has announced additional initial data from its ongoing Phase 1 clinical trial of monoclonal antibody candidate, VYD222, for the prevention of symptomatic Covid-19 in immunocompromised people.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 11:08 am